Jean-Philippe Lacour

Jean-Philippe LACOUR is currently the Head of Global Vigilance Operations - Interventional Imaging at Guerbet since December 2021. Prior to that, they served as the Global drug safety officer at Guerbet from July 2017 to December 2021. Jean-Philippe also worked as a Pharmacien Pharmacovigilant at Axpharma from March 2016 to July 2017. Jean-Philippe has experience as a Stagiaire - Chargé de pharmacovigilance at Bristol-Myers Squibb from March 2015 to October 2015, where they evaluated data for immuno-oncology products and managed pharmacovigilance cases. Jean-Philippe was also a Stagiaire évaluateur pharmacovigilance - DP oncologie, hématologie, néphrologie et immunologie at ANSM (Agence Nationale de Sécurité des Médicaments) from April 2014 to September 2014, evaluating safety data and individual pharmacovigilance cases. Before that, they worked as an Assistant technico réglementaire at CEHTRA from September 2012 to August 2013, and as an Assistant affaires réglementaires at Pfizer from January 2012 to July 2012, and at Sanofi from May 2011 to August 2011.

Jean-Philippe LACOUR completed their education at Paris-Sud University (Paris XI). In 2015, they earned a Master 2 (M2) in "toxicologie, évaluation des risques et vigilances" with a focus on pharmacovigilance and toxicology. Prior to that, from 2007 to 2015, they obtained a Doctor of Pharmacy (PharmD) degree in the field of pharmacie.